SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a high-risk viral agent involved in the recent pandemic stated worldwide by the World Health Organization. The infection is correlated to a severe systemic and respiratory disease in many cases, which is clinically treated with a mu...

Full description

Saved in:
Bibliographic Details
Published in:Microorganisms (Basel) 2021-03, Vol.9 (3), p.525
Main Authors: Inchingolo, Alessio Danilo, Inchingolo, Angelo Michele, Bordea, Ioana Roxana, Malcangi, Giuseppina, Xhajanka, Edit, Scarano, Antonio, Lorusso, Felice, Farronato, Marco, Tartaglia, Gianluca Martino, Isacco, Ciro Gargiulo, Marinelli, Grazia, D'Oria, Maria Teresa, Hazballa, Denisa, Santacroce, Luigi, Ballini, Andrea, Contaldo, Maria, Inchingolo, Francesco, Dipalma, Gianna
Format: Article
Language:English
Subjects:
Adjuvant therapy
Age groups
Asymptomatic
Chronic obstructive pulmonary disease
Coronaviruses
COVID-19
Disease prevention
Disease transmission
Evaluation
Fatalities
furin
Headache
Hospitalization
Immune system
Infections
Intensive care
Intestine
Masks
Melatonin
Mortality
Older people
oral mucosa
Pandemics
Pediatrics
Pneumonia
Population
Respiratory diseases
Resveratrol
Review
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Signs and symptoms
Stainless steel
Tachycardia
Viral diseases
Vitamin D
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a high-risk viral agent involved in the recent pandemic stated worldwide by the World Health Organization. The infection is correlated to a severe systemic and respiratory disease in many cases, which is clinically treated with a multi-drug pharmacological approach. The purpose of this investigation was to evaluate through a literature overview the effect of adjuvant therapies and supplements for the SARS-CoV-2 infection. The research has analyzed the advantage of the EK1C4, by also assessing the studies on the resveratrol, vitamin D, and melatonin as adjuvant supplements for long hauler patients' prognosis. The evaluated substances reported important benefits for the improvement of the immune system and as a potential inhibitor molecules against SARS-CoV-2, highlighting the use of sartans as therapy. The adjuvant supplements seem to create an advantage for the healing of the long hauler patients affected by chronic symptoms of constant chest and heart pain, intestinal disorders, headache, difficulty concentrating, memory loss, and tachycardia.
ISSN:2076-2607
2076-2607
DOI:10.3390/microorganisms9030525